Corbus Pharmaceuticals Holdings (CRBP) Revenue (2015 - 2021)

Corbus Pharmaceuticals Holdings has reported Revenue for 7 years, with the latest figure at $97323.0 in Q3 2021.

• On a quarterly basis, Revenue fell 92.09% year-over-year to $97323.0 in Q3 2021; TTM through Jun 2022 was $97323.0, a 96.36% decrease from a year earlier, with the FY2021 full-year figure at $881705.0, down 77.61% from the prior year.
• Revenue was $97323.0 for Q3 2021 at Corbus Pharmaceuticals Holdings, down from $136558.0 in the prior quarter.
• The five-year high for Revenue was $29.1 million in Q2 2019, with the low at $97323.0 in Q3 2021.
• Average Revenue over 5 years is $2.7 million, with a median of $1.0 million recorded in 2018.
• The sharpest annual moves came in 2019 and 2020: Revenue soared 3308.27% in 2019, then tumbled 99.02% in 2020.
• Over 5 years, Revenue stood at $796312.0 in 2017, then jumped by 142.03% to $1.9 million in 2018, then jumped by 33.53% to $2.6 million in 2019, then tumbled by 74.42% to $658204.0 in 2020, then tumbled by 85.21% to $97323.0 in 2021.
• The last three Revenue figures came in at $97323.0 (Q3 2021), $136558.0 (Q2 2021), and $647824.0 (Q1 2021), per Business Quant data.